LVCT Health is leading the implementation of the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) project in Kenya. MOSAIC, a five-year (2021-2026) global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID) has a goal to help women prevent HIV by accelerating the introduction and scale-up of new and emerging biomedical prevention products. To achieve this goal, MOSAIC has identified five strategic priorities which are:
- Promote a user-centred approach in which the needs and preferences of users especially adolescent girls and young women (AGYW) are understood and addressed in product introduction and scale-up
- Conduct research to expand the evidence base on how to effectively enhance product availability, acceptability, uptake, and effective use
- Coordinate and provide technical assistance to global, national, and subnational stakeholders to expedite product introduction in policy and programs by addressing issues related to regulatory review, policy development, resource mobilization, supply chain, delivery models and platforms, monitoring and evaluation, surveillance, and demand generation
- Implement research utilization activities and establish mechanisms for rapid, effective knowledge exchange among key stakeholders to facilitate application of existing and emerging evidence on product introduction in policy and programs
- Strengthening and sustaining local partner capacityto advocate for the design and implementation of high-quality product introduction activities and research.
Under the strategic priority number 5 on strengthening and sustaining local partner capacity for MOSAIC, LVCT Health seeks to engage Community Based Organizations and Civil Society Organizations (CBOs/CSOs) (as defined under section 5 of this call) that will be provided with capacity strengthening activities focusing on technical and research competencies, including in community/youth engagement, community mobilization, community education/literacy on biomedical HIV prevention options, Psychosocial support activities to support uptake and effective use of PrEP, advocacy, and demand creation. Successful CBOs/CSOs will also be provided with subgrants to perform some of the essential functions that support the introduction of HIV prevention products.